New Drugs Offer Hope for Alzheimer's
New antibody drugs are offering a significant breakthrough in the fight against Alzheimer's disease, demonstrating the ability to slow cognitive decline in individuals with early-onset forms of the condition by targeting and removing amyloid plaques. This promising development, spearheaded by research at institutions like Washington University School of Medicine and supported by substantial funding, aims to intervene before symptoms fully manifest, potentially extending cognitive function for patients.
